Synapsoft logo
AI Insights from Disclosures
Searching...
Aprogen, Inc 007460
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Aprogen, Inc engages in (1) the hardfacing business and (2) the steel sales business, as well as (3) the pharmaceutical business of its consolidated subsidiaries Aprogen Biologics Co., Ltd. and AP Healthcare Co., Ltd. (formerly Aprogen Healthcare & Games Co., Ltd.), and (4) the insulation construction business, including the Nukon System for special insulation of nuclear power plants, of its consolidated subsidiary Aprogen I&C Co., Ltd., which was spun off from the company on June 1, 2021; it also has (5) a biopharmaceuticals division. The main business of the company that was absorbed and merged into the company on July 18, 2022 belongs to the biopharmaceuticals division, developing and producing biopharmaceuticals centered on therapeutic proteins such as autoimmune disease treatments and anticancer agents, based on humanized antibody engineering technology, recombinant protein design technology, superior cell-line production technology, and cell culture optimization technology.
Representative Director Kim Jaeseop
Founded November 15, 1971
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0122731
Business number 219-81-00146
Phone Number 031-782-3433
Fax Number 031-8022-0592
Website www.aprogen.com
Company Address 545 Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant